FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 352:740 February 17, 2005 Number 7

	Since this article has no abstract, we have provided an extract of the first 100% of the full text and any section headings.

	Full Text PDF PDA Full Text Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by Falini, B.

Cytoplasmic Nucleophosmin in Acute Myelogenous Leukemia with a Normal Karyotype . On page 263, in Panel B of Figure 4, the data under the column heading "No./No. of Cases (%)" are incorrect. They should read, according to the type of mutation, as follows: for none (wild-type), no data; for mutation A, 40/51 (78); for mutation B, 7/51 (14); for mutation C, 1/51 (2); for mutation D, 1/51 (2); for mutation E, 1/51 (2); and for mutation F, 1/51 (2).

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.